Monthly Archives: March 2017

//March

Dupilumab – Horror Movie

By | March 31st, 2017|Dupilumab|

In recounting the diagnosis, management and cure of 4000 corticosteroid addicted atopic dermatitis patients I feel like I am in a futuristic movie with a split screen simultaneously showing two similar populations. One population is now in the present consisting of suffering patients who go on to CURE – albeit through a prolonged period of [...]

Dupilumab Study – Journal Articles

By | March 30th, 2017|Dupilumab|

Dupilumab is now FDA approved as of March 28, 2017 and this event necessitates a further evaluation for the prospects of this drug helping eczema patients. Physicians and patients are being told the published results but they deserve an objective critique. There are multiple discrepancies and violations of true, honest research and in looking at [...]

Dupilumab: Further Comments

By | March 28th, 2017|Dupilumab|

After having cured 4000 plus patients with steroid addiction and Red Skin Syndrome, I feel duty bound to offer sound advice to those still mismanaged suffering patients still floundering in their care. In that regard I look at every new drug offering promise of improvement or cure to these patients. I dissect the quality of [...]

Dupilumab Study

By | March 22nd, 2017|Dupilumab, RSS Patients|

The following are comments by Marvin Rapaport MD, owner of this website, Red Skin Syndrome, and edited and clearly written by an esteemed writer and journalist, Ruchy Reese, who writes for the monthly magazine, Wellspring.   I am writing in response to an article that appeared in the December 15, 2016 edition of the New [...]

My Journey

By | March 14th, 2017|Information on Red Skin Syndrome, Topical Steroid Withdrawal|

Dr. Rapaport, I recently came across one of the pictures of my Topical Steroid Withdrawal/Red Skin Syndrome (TSW/RSS) journey. It was of my lips – swollen, red, burning, peeling, splitting. Some symptoms were apparent before stopping TS, yet several dermatologists continued to prescribe them, Protopic and Elidel. I also endured probably all of the other [...]